WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Stock Ownership - Who owns Cognition Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cognition Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Lisa RicciardiCEO President2024-03-145,700$1.75
$9.98kBuy
Anthony CaggianoChief Medical Officer2024-02-0312,777$2.29
$29.26kSell
Lisa RicciardiCEO President2024-02-0327,828$2.29
$63.73kSell
Aaron Gl FletcherDirector2023-11-08500,095$1.05
$525.10kBuy
Leslie W. KreisDirector2023-11-08500,095$1.05
$525.10kBuy

1 of 1

CGTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGTX insiders and whales buy or sell their stock.

CGTX Shareholders

What type of owners hold Cognition Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher26.22%10,226,718$19.43MInsider
Leslie W. Kreis16.19%6,313,877$12.00MInsider
Bios Memory Spv I LP10.03%3,912,841$7.43MInsider
Ogden Cap Associates LLC5.67%2,210,377$4.20MInsider
Pathstone Holdings LLC5.65%2,205,377$4.19MInstitution
Aigh Capital Management LLC5.23%2,038,853$3.87MInstitution
Vanguard Group Inc1.85%721,554$1.37MInstitution
Worth Venture Partners LLC1.30%508,719$966.57kInstitution
Bios Clinical Opportunity Fund LP1.28%500,095$950.18kInsider
Mark H. Breedlove1.06%412,050$782.90kInsider

1 of 3

CGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGTX18.34%62.09%Net BuyingNet Selling
GNTA2.53%0.00%
CARM21.66%74.42%
ANTX54.22%45.78%Net Buying
GRTS42.92%22.23%Net Buying
View Top Biotech Stocks

Cognition Therapeutics Stock Ownership FAQ

Who owns Cognition Therapeutics?

Cognition Therapeutics (NASDAQ: CGTX) is owned by 18.34% institutional shareholders, 62.09% Cognition Therapeutics insiders, and 19.56% retail investors. Aaron Gl Fletcher is the largest individual Cognition Therapeutics shareholder, owning 10.23M shares representing 26.22% of the company. Aaron Gl Fletcher's Cognition Therapeutics shares are currently valued at $18.82M.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.